Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Apellis Pharmaceuticals, Inc.

APLSNASDAQ
Healthcare
Biotechnology
$40.23
$23.14(135.40%)
U.S. Market opens in 15h 33m

APLS News Today: Stay Updated with the Latest Apellis Pharmaceuticals, Inc. News in Real Time

Find APLS news now at Meyka AI. Stay informed with the latest Apellis Pharmaceuticals, Inc. stocks updates, including price news, market analysis, and expert insights.

0Q3.DE Beyond Meat XETRA earnings after close 31 Mar 2026: cash burn in focus
📅 in about 5 hours

0Q3.DE Beyond Meat XETRA earnings after close 31 Mar 2026: cash burn in focus

0Q3.DE stock moved after Beyond Meat earnings on 31 Mar 2026; focus on cash, margins and a EUR 0.63 model forecast

Read more
BofA Maintains Neutral, Cowen Maintains Hold on Freshpet (FRPT) March 2026
📅 in about 5 hours

BofA Maintains Neutral, Cowen Maintains Hold on Freshpet (FRPT) March 2026

FRPT analyst rating update: BofA and Cowen maintained ratings on Freshpet on March 17, 2026

Read more
PGTK stock falls to $0.0009 on PNK Mar 31 2026: what investors should watch
📅 in about 2 hours

PGTK stock falls to $0.0009 on PNK Mar 31 2026: what investors should watch

PGTK stock at $0.0009 on PNK (31 Mar 2026). Analysis of drivers, grade, and forecast

Read more
CLIQ.TO Alcanna (TSX) C$9.05 intraday 31 Mar 2026: Oversold bounce signals rebound
📅 in 25 minutes

CLIQ.TO Alcanna (TSX) C$9.05 intraday 31 Mar 2026: Oversold bounce signals rebound

Intraday oversold bounce on CLIQ.TO stock at C$9.05; technical setup, fundamentals and Meyka AI forecast C$10.50

Read more
PEP.SW PepsiCo (SIX) +6.84% after hours 31 Mar 2026: volume spike signals renewed trading interest
📅 1 hour ago

PEP.SW PepsiCo (SIX) +6.84% after hours 31 Mar 2026: volume spike signals renewed trading interest

PEP.SW stock jumps in after hours on 31 Mar 2026 on a clear volume spike, trading at CHF125.00 with analyst-grade context

Read more
Pre-market 4259.T ExaWizards JPY 561.00: AI stocks face valuation test
📅 1 hour ago

Pre-market 4259.T ExaWizards JPY 561.00: AI stocks face valuation test

Pre-market 4259.T stock update: ExaWizards at JPY 561.00, forecasts and Meyka grade for AI stocks

Read more
BRAS.CN stock down 50.00% to C$0.005 in market hours: we flag liquidity and valuation risk
📅 2 hours ago

BRAS.CN stock down 50.00% to C$0.005 in market hours: we flag liquidity and valuation risk

BRAS.CN stock drops 50.00% to C$0.005 in market hours; Meyka AI forecast C$3.89 model projection, high liquidity risk

Read more
Biogen to Buy Apellis in $5.6 Billion All‑Cash Deal
📅 4 hours ago

Biogen to Buy Apellis in $5.6 Billion All‑Cash Deal

Biotech giant Biogen announced a major deal to acquire Apellis Pharmaceuticals for $5.6 billion in cash, marking one of the largest strategic transactions in the sector this year. The acquisition is aimed at strengthening Biogen’s drug pipeline, especially in areas such as eye disease and immunology where Apellis has developed promising therapies. Investors reacted strongly…

Read more
Centessa Shares Soar Following Lilly’s $6.3B Acquisition Announcement
📅 4 hours ago

Centessa Shares Soar Following Lilly’s $6.3B Acquisition Announcement

The stock market reacted strongly after a major acquisition announcement involving Centessa Shares. Eli Lilly, one of the largest pharmaceutical companies in the world, confirmed it will acquire Centessa Pharmaceuticals for $6.3 billion in an all‑cash deal. This news caused Centessa Shares to surge sharply, making the acquisition one of the most talked‑about deals in…

Read more

APLS News FAQ